Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With de Novo Coronary Artery Lesions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00371475
What this trial is testing

The TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Boston Scientific Corporation 150
Not applicableStudy completedNCT01507519
What this trial is testing

Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions

Who this might be right for
Coronary Artery Disease
Meril Life Sciences Pvt. Ltd. 30
Not applicableLooking for participantsNCT07190690
What this trial is testing

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Fundación EPIC 2,100
Not applicableLooking for participantsNCT06742931
What this trial is testing

Drug-Coated Balloon Versus Drug-Eluting Stent for Treatment of De-Novo Coronary Lesions in Patients With High Bleeding Risk-2

Who this might be right for
Chronic Coronary Syndrome
Samsung Medical Center 1,200
Not applicableUnknownNCT02305472
What this trial is testing

NeoVas Bioresorbable Coronary Scaffold Registry Study

Who this might be right for
Coronary Artery Disease
Lepu Medical Technology (Beijing) Co., Ltd. 825
Testing effectiveness (Phase 2)Study completedNCT01247428
What this trial is testing

First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Micell Technologies 30
Large-scale testing (Phase 3)Study completedNCT00371423
What this trial is testing

Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Boston Scientific Corporation 247
Testing effectiveness (Phase 2)Study completedNCT00233792
What this trial is testing

FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 30
Not applicableStudy completedNCT01426139
What this trial is testing

BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Biotronik AG 120
Large-scale testing (Phase 3)Study completedNCT00232765
What this trial is testing

Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 1,058
Testing effectiveness (Phase 2)Study completedNCT00233818
What this trial is testing

FIM-NL - First-in-Man Study (Netherlands Part) With Sirolimus Coated Modified BX Velocity Stent

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 15
Not applicableTemporarily pausedNCT02916485
What this trial is testing

Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal Scaffold

Who this might be right for
Coronary Artery Disease
Biotronik AG 100
Not applicableStudy completedNCT04937803
What this trial is testing

Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)

Who this might be right for
Drug-Coated BalloonDe Novo StenosisAcute Coronary Syndromes+4 more
Harbin Medical University 216
Large-scale testing (Phase 3)Study completedNCT00232739
What this trial is testing

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 100
Not applicableLooking for participantsNCT06271590
What this trial is testing

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

Who this might be right for
Coronary Artery DiseaseNative Coronary Artery StenosisCardiovascular Diseases
Concept Medical Inc. 1,605
Not applicableStudy completedNCT05096442
What this trial is testing

Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions

Who this might be right for
Coronary Artery Disease
Genoss Co., Ltd. 204
Not applicableLooking for participantsNCT07303439
What this trial is testing

Randomised Trial of Dual Device Treatment Involving Drug-coated Balloon Angioplasty and Drug-eluting Stent Implantation Compared to Single Device Treatments in Patients With Diabetes Mellitus

Who this might be right for
Diabetes MellitusCoronary Arterial Disease (CAD)de Novo Coronary Lesions+1 more
Royal College of Surgeons, Ireland 120
Not applicableStudy completedNCT02013349
What this trial is testing

DESolve Post-Approval Study

Who this might be right for
Coronary Artery Disease
Elixir Medical Corporation 102
Testing effectiveness (Phase 2)Study completedNCT01294748
What this trial is testing

Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Micell Technologies 184
Not applicableStudy completedNCT03817801
What this trial is testing

Comparison of Scoring Balloon and Conventional Balloon Predilation Before Drug Coated Balloon for de Novo Lesion in Patients With High Bleeding Risk

Who this might be right for
Coronary Artery Disease
Nanjing First Hospital, Nanjing Medical University 60
Next Page